Recruiting now
-
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Phase 2 · 140 people · 48 sites in 8 countries · Recruiting now
-
ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer
Phase 3 · randomised · 103 people · 25 sites in Netherlands · Recruiting now
-
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Phase 2 · randomised · 90 people · 18 sites in 2 countries · Recruiting now
-
Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
Phase 3 · randomised · 131 people · 4 sites in 2 countries · Recruiting now
-
Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer
Phase 3 · randomised · 236 people · 13 sites in South Korea · Recruiting now
-
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Phase 2 · randomised · 482 people · 14 sites in 5 countries · Recruiting now